Sagimet amends executive severance agreements with CEO, CFO, and NEO

Sagimet Biosciences Inc.

CEO David Happel gets 24 months base salary, target bonus, equity acceleration on change-in-control termination.
CFO Thierry Chauche and NEO Eduardo Martins get 15 months severance under same conditions.
Annual meeting elected Elizabeth Grammer and Beth Seidenberg as Class II directors; ratified Deloitte & Touche as auditor.

item 5.02item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.